ResearcherNational Institutes of HealthNo recent work listed
James B. Mitchell
Matched on ORCID iD 0000-0003-1396-6499; OpenAlex author ID A5104110040; NIH RePORTER profile ID 9692291. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 1
- Labs led
- 0
- Collaborators
- 9
2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper, 1 grant
Papers 6
- Evofosfamide and Gemcitabine Act Synergistically in Pancreatic Cancer Xenografts by Dual Action on Tumor Vasculature and Inhibition of Homologous Recombination… Co-author DOI 10.1089/ars.2022.0118↗
- PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. A molecular imaging study. Co-author DOI 10.1016/j.neo.2022.100793↗
- Hypoxia-Activated Prodrug Evofosfamide Treatment in Pancreatic Ductal Adenocarcinoma Xenografts Alters the Tumor Redox Status to Potentiate Radiotherapy. Co-author DOI 10.1089/ars.2020.8131↗
- Reoxygenation after Evofosfamide Treatment in Pancreatic Ductal Adenocarcinoma Xenografts is due to Decreased Oxygen Consumption and not Increased Oxygen Supply Co-author DOI 10.1101/2020.05.16.099853↗
- Molecular Imaging of the Tumor Microenvironment Reveals the Relationship between Tumor Oxygenation, Glucose Uptake, and Glycolysis in Pancreatic Ductal Adenoca… Co-author DOI 10.1158/0008-5472.can-19-0928↗
- Imaging of glucose metabolism by 13C-MRI distinguishes pancreatic cancer subtypes in mice. Co-author DOI 10.7554/elife.46312↗
Grants 1
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jeffrey Brender · 6 shared papers, 2019–2023 · strength 0.78
- Paper Evofosfamide and Gemcitabine Act Synergistically in Pancreatic Cancer Xenografts by Dual Action on Tumor Vasculature an… DOI 10.1089/ars.2022.0118↗
- Paper Hypoxia-Activated Prodrug Evofosfamide Treatment in Pancreatic Ductal Adenocarcinoma Xenografts Alters the Tumor Redox … DOI 10.1089/ars.2020.8131↗
- Paper PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. … DOI 10.1016/j.neo.2022.100793↗
- Kazutoshi Yamamoto · 6 shared papers, 2019–2023 · strength 0.78
- Paper Evofosfamide and Gemcitabine Act Synergistically in Pancreatic Cancer Xenografts by Dual Action on Tumor Vasculature an… DOI 10.1089/ars.2022.0118↗
- Paper Hypoxia-Activated Prodrug Evofosfamide Treatment in Pancreatic Ductal Adenocarcinoma Xenografts Alters the Tumor Redox … DOI 10.1089/ars.2020.8131↗
- Paper PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. … DOI 10.1016/j.neo.2022.100793↗
- Shun Kishimoto · 6 shared papers, 2019–2023 · strength 0.78
- Paper Evofosfamide and Gemcitabine Act Synergistically in Pancreatic Cancer Xenografts by Dual Action on Tumor Vasculature an… DOI 10.1089/ars.2022.0118↗
- Paper Hypoxia-Activated Prodrug Evofosfamide Treatment in Pancreatic Ductal Adenocarcinoma Xenografts Alters the Tumor Redox … DOI 10.1089/ars.2020.8131↗
- Paper PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. … DOI 10.1016/j.neo.2022.100793↗
- Murali Cherukuri Krishna · 6 shared papers, 2019–2023 · strength 0.78
- Paper Evofosfamide and Gemcitabine Act Synergistically in Pancreatic Cancer Xenografts by Dual Action on Tumor Vasculature an… DOI 10.1089/ars.2022.0118↗
- Paper Hypoxia-Activated Prodrug Evofosfamide Treatment in Pancreatic Ductal Adenocarcinoma Xenografts Alters the Tumor Redox … DOI 10.1089/ars.2020.8131↗
- Paper PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. … DOI 10.1016/j.neo.2022.100793↗
- Yasunori Otowa · 2 shared papers, 2022–2023 · strength 0.32
- Paper Evofosfamide and Gemcitabine Act Synergistically in Pancreatic Cancer Xenografts by Dual Action on Tumor Vasculature an… DOI 10.1089/ars.2022.0118↗
- Paper PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. … DOI 10.1016/j.neo.2022.100793↗
- Tomohiro Seki · 3 shared papers, 2019–2022 · strength 0.32
- Paper PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. … DOI 10.1016/j.neo.2022.100793↗
- Paper Molecular Imaging of the Tumor Microenvironment Reveals the Relationship between Tumor Oxygenation, Glucose Uptake, and… DOI 10.1158/0008-5472.can-19-0928↗
- Paper Imaging of glucose metabolism by 13C-MRI distinguishes pancreatic cancer subtypes in mice. DOI 10.7554/elife.46312↗
- peter L choyke · 2 shared papers, 2019–2020 · strength 0.17
- William Marston Linehan · 1 shared paper, 2019 · strength 0.07
- Daniel R. Crooks · 1 shared paper, 2019 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.